Invention Application
- Patent Title: INHIBITORS OF FLAVIVIRIDAE VIRUSES
-
Application No.: US13958424Application Date: 2013-08-02
-
Publication No.: US20130323203A1Publication Date: 2013-12-05
- Inventor: Eda Canales , Lee S. Chong , Michael O'Neil Hanrahan Clarke , Edward Doerffler , Scott E. Lazerwith , Willard Lew , Michael Mertzman Belmont , Philip Anthony Morganelli , William J. Watkins
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: C07D333/38
- IPC: C07D333/38 ; A61K31/4545 ; A61K45/06 ; C07D409/12 ; A61K31/381 ; A61K31/501 ; C07D493/04 ; A61K31/4535 ; A61K31/454 ; A61K31/497 ; C07D413/12 ; A61K31/427 ; C07D409/14 ; A61K31/4025
Abstract:
Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
Public/Granted literature
- US08884030B2 Inhibitors of Flaviviridae viruses Public/Granted day:2014-11-11
Information query
